Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
6.28
+0.42 (7.17%)
Dec 20, 2024, 4:00 PM EST - Market closed
Enanta Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2019 - 2015 |
Cash & Equivalents | 37.23 | 37.23 | 85.39 | 43.99 | 57.21 | 87.13 | Upgrade
|
Short-Term Investments | 210.95 | 210.95 | 284.52 | 205.24 | 186.8 | 299.52 | Upgrade
|
Cash & Short-Term Investments | 248.19 | 248.19 | 369.91 | 249.23 | 244 | 386.65 | Upgrade
|
Cash Growth | -32.91% | -32.91% | 48.42% | 2.14% | -36.89% | 15.34% | Upgrade
|
Accounts Receivable | 6.65 | 6.65 | 8.61 | 20.32 | 23.58 | 23.49 | Upgrade
|
Other Receivables | 32 | 32 | 31 | 28.72 | 37.26 | 13.04 | Upgrade
|
Receivables | 38.65 | 38.65 | 39.62 | 49.04 | 60.83 | 36.53 | Upgrade
|
Prepaid Expenses | 12.41 | 12.41 | 13.26 | 13.45 | 14.19 | 13.66 | Upgrade
|
Restricted Cash | 0.61 | 0.61 | - | - | - | - | Upgrade
|
Total Current Assets | 299.85 | 299.85 | 422.79 | 311.71 | 319.02 | 436.84 | Upgrade
|
Property, Plant & Equipment | 73.35 | 73.35 | 34.71 | 29.75 | 10.65 | 15.62 | Upgrade
|
Long-Term Investments | - | - | - | 29.29 | 108.42 | 32.63 | Upgrade
|
Long-Term Deferred Tax Assets | - | - | - | - | - | 0.35 | Upgrade
|
Other Long-Term Assets | 3.45 | 3.45 | 4.77 | 4.66 | 0.7 | 0.7 | Upgrade
|
Total Assets | 376.65 | 376.65 | 462.28 | 375.41 | 438.79 | 486.13 | Upgrade
|
Accounts Payable | 8 | 8 | 4.1 | 6 | 9.54 | 5.74 | Upgrade
|
Accrued Expenses | 13.55 | 13.55 | 18.34 | 20.94 | 22.43 | 14.16 | Upgrade
|
Current Portion of Long-Term Debt | 34.46 | 34.46 | 35.08 | - | - | - | Upgrade
|
Current Portion of Leases | 1.52 | 1.52 | 5.28 | 2.89 | 4.2 | 4.26 | Upgrade
|
Total Current Liabilities | 57.54 | 57.54 | 62.79 | 29.83 | 36.17 | 24.16 | Upgrade
|
Long-Term Debt | 136.13 | 136.13 | 160.85 | 1.42 | 1.51 | 1.48 | Upgrade
|
Long-Term Leases | 53.94 | 53.94 | 21.24 | 22.37 | 1.13 | 3.84 | Upgrade
|
Other Long-Term Liabilities | 0.23 | 0.23 | 0.66 | 0.45 | 0.56 | 1.08 | Upgrade
|
Total Liabilities | 247.84 | 247.84 | 245.54 | 54.08 | 39.36 | 30.55 | Upgrade
|
Common Stock | 0.21 | 0.21 | 0.21 | 0.21 | 0.2 | 0.2 | Upgrade
|
Additional Paid-In Capital | 451.34 | 451.34 | 424.69 | 398.03 | 351.03 | 326.96 | Upgrade
|
Retained Earnings | -323.04 | -323.04 | -207 | -73.18 | 48.58 | 127.57 | Upgrade
|
Comprehensive Income & Other | 0.3 | 0.3 | -1.17 | -3.72 | -0.38 | 0.84 | Upgrade
|
Shareholders' Equity | 128.81 | 128.81 | 216.74 | 321.33 | 399.43 | 455.58 | Upgrade
|
Total Liabilities & Equity | 376.65 | 376.65 | 462.28 | 375.41 | 438.79 | 486.13 | Upgrade
|
Total Debt | 226.06 | 226.06 | 222.44 | 26.69 | 6.84 | 9.58 | Upgrade
|
Net Cash (Debt) | 22.13 | 22.13 | 147.47 | 251.83 | 345.58 | 409.71 | Upgrade
|
Net Cash Growth | -84.99% | -84.99% | -41.44% | -27.13% | -15.65% | 2.86% | Upgrade
|
Net Cash Per Share | 1.05 | 1.05 | 7.03 | 12.22 | 17.13 | 20.55 | Upgrade
|
Filing Date Shares Outstanding | 21.19 | 21.19 | 21.06 | 20.8 | 20.32 | 20.08 | Upgrade
|
Total Common Shares Outstanding | 21.19 | 21.19 | 21.06 | 20.79 | 20.24 | 20.08 | Upgrade
|
Working Capital | 242.32 | 242.32 | 360 | 281.89 | 282.85 | 412.68 | Upgrade
|
Book Value Per Share | 6.08 | 6.08 | 10.29 | 15.46 | 19.74 | 22.69 | Upgrade
|
Tangible Book Value | 128.81 | 128.81 | 216.74 | 321.33 | 399.43 | 455.58 | Upgrade
|
Tangible Book Value Per Share | 6.08 | 6.08 | 10.29 | 15.46 | 19.74 | 22.69 | Upgrade
|
Machinery | 19.92 | 19.92 | 19.14 | 16.79 | 16.32 | 15.82 | Upgrade
|
Construction In Progress | 22.75 | 22.75 | 1.27 | 2.56 | 0.02 | - | Upgrade
|
Leasehold Improvements | 13.98 | 13.98 | 13.8 | 7.28 | 7.14 | 7.09 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.